BIT Header Desktop  
BIT Header Mobile 
 

Track 8 - April 21 – 23, 2015

Pharmaceutical R&D Informatics 

Collaboration, Data Science and Biologics

With the increased generation of innumerable and varied data sets, pharma and biotech must effectively manage and integrate data from all stages of the pharmaceutical value chain to enable more informed decisions. This is seen in the emerging trend of data science groups. Track 8 explores the transformation of current IT and informatics teams into data science groups and current progress made by such groups in the analysis, integration and visualization of complex data sets, including genomic, imaging, clinical, external/internal collaboration and real world data.

Preliminary Agenda

Download Brochure | Workshops 

The Evolution of Data Science in Translational Medicine

Anastasia Christianson, Head, Translational R&D IT, Bristol-Myers Squibb

Eric Carleen, Director, Data Science, Bristol-Myers Squibb

Data Science in Translational Clinical Research

James Cai, Head, Data Science, Translational Clinical Research Center, Roche

The Construction of a Scientific Modeling Culture and Technology Platform at Merck

Chris L. Waller, Ph.D., Director, Scientific Modeling Platforms, Merck

Separating the Wheat from the Chaff: Using Proprietary and Public Genomic Information to Identify Biomarkers from Cancer Cell Line Profiling Studies

Yue Webster, Ph.D., Senior Research Scientist, LRL IT Informatics, Eli Lilly and Company

Translational R&D Analytics: Delivering ‘Big Insights’ to Drive Translational Research

Kaushal Desai, Associate Director, Translational R&D Analytics and Decision-Support, Research Informatics & Automation, Bristol-Myers Squibb

Integrated Genomics Platform: Putting Patients and their Genomes into the Focus of our Research

Philip Groth, Ph.D., IT Business Partner Oncology & Genomics, Bayer Healthcare

Beyond Data Integration – Consumable Expert Knowledge in Chemical Biology

Jeremy L. Jenkins, Ph.D., Senior Investigator II, High-Throughput Biology, Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research

Integrating and Exposing Preclinical Drug Development Data – An AstraZeneca Perspective

Mark Pinches, Senior Scientist, Drug Safety and Metabolism, AstraZeneca

Development and Implementation of a Nonclinical Data Warehouse

Gregory Woo, Principal IS Business Systems Analyst, Research & Development Informatics, Amgen, Inc.

Public Bioactivity and Patent Data: The ChEMBL Platform for Drug Discovery

Mark Davies, Ph.D., Computational Chemical Biology, European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus

Text Mining from Bench to Bedside - Where’s the Value?

Jane Reed, Ph.D., Head, Life Science Strategy, Linguamatics



View 2015 Brochure
 BIT-Agenda-icon 
 

Platinum Sponsors
 

 Cycle Computing logo 

 Data Direct Networks 

Elsevier 

 

IBM 

Illumnia logo 

Intel Logo 

OKTA 

Oracle Health Sciences 

Seagate  

 

Thinkmate 

Thomson Reuters 


View All Sponsors 

 


Official Media Partner
  


View Media Partners 


Conference CD

CD iconOrder the 2014 event proceedings - now available on CD 


Complimentary Downloads

View white papers, listen to podcasts, and more! 

  • Making the World's Knowledge Computable
  • Bioinformatics in the Cloud
  • The Application of Text Analytics to Drug Safety Surveillance
 

Related Events

 HIT Logo for BIT 2015
CLN Co-located Event